Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term terlipressin for cirrhosis with ascites and sarcopenia
ACTRN12619000891123Phase 3Completed
- Sponsor
- Austin Health
- Start
- Jul 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of terlipressin in Cirrhosis, sponsored by Austin Health. Primary endpoints: Change in muscle strength and Effect on ascites. Started Jul 2019; status: completed.
02
Drugs
terlipressin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ACTRN12619000891123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000891123.